Dr. Noriko Tei Boyd Anderson, MD, MPH

Dr. Anderson practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Anderson's NPI, 1841617925, was assigned on March 26, 2014. Dr. Anderson graduated from UCSF School of Medicine in 2014. Dr. Anderson holds California license A141072.

Dr. Anderson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Anderson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Anderson to 5 more medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Anderson is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Anderson is licensed in California.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, head injury, hereditary polyneuropathy, lower back pain, migraine and chronic headache and muscle disease among the conditions Dr. Anderson treats.

CMS data shows 263 Medicare services from Dr. Anderson across 5 procedure codes in 2024, for 190 Medicare patients. Medicare paid $21,057 for them.

CMS counts 190 Medicare patients who saw Dr. Anderson in 2024. The largest group is 65 to 74, with 75 patients. 67% of them have high cholesterol, and 63% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 65, with 63% women.

In 2024, Dr. Anderson wrote 415 Medicare Part D claims for 93 patients. 80% of them were for generic drugs. CMS names the drug for 276 of them, across 10 drugs with 11 or more claims each, at $376,838 in total drug cost. In 2023, CMS named 332 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Anderson for performance year 2024, reported as part of a group. Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Anderson, published from 2017 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Brachial Plexus Neuritis, Delirium and Electrodiagnosis. Dr. Anderson's most frequent co-authors are Scott A. Josephson, MD, Ethan G. Brown, MD and Vanja Christopher Douglas, MD.

CMS Open Payments shows 2 general payments to Dr. Anderson from 2 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $125.

Dr. Anderson graduated from UCSF School of Medicine in 2014.

Dr. Anderson is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.